Skip to content
Awesome – Lifestyle
Author:
Castle Biosciences, Inc.
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma’s Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
April 28, 2026
←
Previous Page
1
2
3